FDA approves new type of PSA testing methodology


According to a report on the US Food and Drug Administration (FDA) web site, the FDA has just approved the “finger-prick” Sangia Total PSA blood test developed by OPKO Diagnostics.

It seems likely that many urology practices will be interested in using a method like this for PSA testing over the next couple of years, since it will mean (effectively) instant access to patients’ PSA data at the time of their regular visits — as opposed to the irritating wait required when blood samples have to be sent to outside laboratories for processing.

However, … a lot will depend on the economic factors affecting acquisition of necessary technology and the space required for the testing equipment.

What is unlikely to happen is that you will be able to get such a test at your primary care physicians’ offices.

One Response

  1. Suggest you read the Summary of Safety and Effectiveness Data (SSED), included in the link above to the article on the FDA web site.

    This new test certainly appears to be more accurate than the other fingerstick test that has been available for years.

    I am also interested in the cost.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: